Page 106 - 2023-05-中国全科医学

2023年2月 第26卷 第5期 http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn ·619·

diseases （COVID-19） in the South of Iran［J］. BMC Infect outcomes of adult inpatients with COVID-19 in Wuhan，China：a
Dis，2020，20（1）：427. DOI：10.1186/s12879-020-05128-x. propensity score-matching analysis［J］. Respir Res，2020，21（1）：
［57］SHANG Y F，LIU T，WEI Y C，et al. Scoring systems for 172. DOI：10.1186/s12931-020-01435-8.
predicting mortality for severe patients with COVID-19［J］. ［69］YANG X B，YANG Q Y，WANG Y X，et al. Thrombocytopenia
EClinicalMedicine，2020，24：100426. DOI：10.1016/j. and its association with mortality in patients with COVID-19［J］.
eclinm.2020.100426. J Thromb Haemost，2020，18（6）：1469-1472. DOI：
［58］SHI S B，QIN M，CAI Y L，et al. Characteristics and clinical 10.1111/jth.14848.
significance of myocardial injury in patients with severe coronavirus ［70］YANG X B，YU Y，XU J Q，et al. Clinical course and outcomes
disease 2019［J］. Eur Heart J，2020，41（22）：2070-2079. of critically ill patients with SARS-CoV-2 pneumonia in Wuhan，
DOI：10.1093/eurheartj/ehaa408. China：a single-centered，retrospective，observational
［59］SOARES R，MATTOS L R，RAPOSO L M. Risk factors for study［J］. Lancet Respir Med，2020，8（5）：475-481. DOI：
hospitalization and mortality due to COVID-19 in espírito santo 10.1016/S2213-2600（20）30079-5.
state，Brazil［J］. Am J Trop Med Hyg，2020，103（3）： ［71］YAO Q C，WANG P，WANG X G，et al. A retrospective study
1184-1190. DOI：10.4269/ajtmh.20-0483. of risk factors for severe acute respiratory syndrome coronavirus 2
［60］SUN H Y，NING R Q，TAO Y，et al. Risk factors for mortality in infections in hospitalized adult patients［J］. Pol Arch Intern Med，
244 older adults with COVID-19 in Wuhan，China：a retrospective 2020，130（5）：390-399. DOI：10.20452/pamw.15312.
study［J］. J Am Geriatr Soc，2020，68（6）：E19-23. DOI： ［72］YE W J，CHEN G X，LI X P，et al. Dynamic changes of D-dimer
10.1111/jgs.16533. and neutrophil-lymphocyte count ratio as prognostic biomarkers
［61］VAN GERWEN M，ALSEN M，LITTLE C，et al. Risk factors and in COVID-19［J］. Respir Res，2020，21（1）：169. DOI：
outcomes of COVID-19 in New York City；a retrospective cohort 10.1186/s12931-020-01428-7.
study［J］. J Med Virol，2021，93（2）：907-915. DOI： ［73］YU C Z，LEI Q，LI W K，et al. Clinical characteristics，
10.1002/jmv.26337. associated factors，and predicting COVID-19 mortality risk：
［62］WANG D W，YIN Y M，HU C，et al. Clinical course and outcome a retrospective study in Wuhan，China［J］. Am J Prev Med，
of 107 patients infected with the novel coronavirus，SARS-CoV-2， 2020，59（2）：168-175. DOI：10.1016/j.amepre.2020.05.002.
discharged from two hospitals in Wuhan，China［J］. Crit Care， ［74］YUAN M L，YIN W，TAO Z W，et al. Association of radiologic
2020，24（1）：188. DOI：10.1186/s13054-020-02895-6. findings with mortality of patients infected with 2019 novel
［63］WANG K，ZUO P Y，LIU Y W，et al. Clinical and laboratory coronavirus in Wuhan，China［J］. PLoS One，2020，15（3）：
predictors of in-hospital mortality in patients with coronavirus e0230548. DOI：10.1371/journal.pone.0230548.
disease-2019：a cohort study in Wuhan，China［J］. Clin Infect ［75］ZHANG G Q，HU C，LUO L J，et al. Clinical features and
Dis，2020，71（16）：2079-2088. DOI：10.1093/cid/ciaa538. short-term outcomes of 221 patients with COVID-19 in Wuhan，
［64］WENDEL GARCIA P D，FUMEAUX T，GUERCI P，et al. China［J］. J Clin Virol，2020，127：104364. DOI：10.1016/j.
Prognostic factors associated with mortality risk and disease jcv.2020.104364.
progression in 639 critically ill patients with COVID-19 in Europe： ［76］ZHANG J J，CAO Y Y，TAN G，et al. Clinical，radiological，
initial report of the international RISC-19-ICU prospective and laboratory characteristics and risk factors for severity and
observational cohort［J］. EClinicalMedicine，2020，25： mortality of 289 hospitalized COVID-19 patients［J］. Allergy，
100449. DOI：10.1016/j.eclinm.2020.100449. 2021，76（2）：533-550. DOI：10.1111/all.14496.
［65］XU B，FAN C Y，WANG A L，et al. Suppressed T cell-mediated ［77］ZHANG J，WANG X，JIA X，et al. Risk factors for disease
immunity in patients with COVID-19：a clinical retrospective study severity，unimprovement，and mortality in COVID-19 patients in
in Wuhan，China［J］. J Infect，2020，81（1）：e51-60. Wuhan，China［J］. Clin Microbiol Infect，2020，26（6）：
DOI：10.1016/j.jinf.2020.04.012. 767-772. DOI：10.1016/j.cmi.2020.04.012.
［66］XU J Q，YANG X B，YANG L Y，et al. Clinical course and ［78］孙建华，贺行巍，陈成洋，等 . 新型冠状病毒肺炎患者死亡原
predictors of 60-day mortality in 239 critically ill patients with 因的多因素 logistic 回归分析［J］. 内科急危重症杂志，2020，
COVID-19：a multicenter retrospective study from Wuhan， 26（5）：364-368. DOI：10.11768/nkjwzzzz20200503.
China［J］. Crit Care，2020，24（1）：394. DOI：10.1186/ SUN J H，HE X W，CHEN C Y，et al. Risk factors of deaths
s13054-020-03098-9. in patients with COVID-19：a multivariate logistic regression
［67］YAN X S，LI F，WANG X，et al. Neutrophil to lymphocyte ratio as analysis［J］. Journal of Critical Care in Internal Medicine，
prognostic and predictive factor in patients with coronavirus disease 2020，26（5）：364-368. DOI：10.11768/nkjwzzzz20200503.
2019：a retrospective cross-sectional study［J］. J Med Virol， ［79］覃伟，胡冰竹，张竹，等 . 重症新型冠状病毒肺炎的临床特征
2020，92（11）：2573-2581. DOI：10.1002/jmv.26061. 及死亡因素分析［J］. 中华结核和呼吸杂志，2020，43（8）：
［68］YANG Q，ZHOU Y，WANG X R，et al. Effect of hypertension on 648-653. DOI：10.3760/cma.j.cn112147-20200320-00380.